Late Side Effects of Treatment: Skeletal, Genetic, Central Nervous System, and Oncogenic
- 1 February 1976
- journal article
- review article
- Published by Elsevier in Pediatric Clinics of North America
- Vol. 23 (1) , 233-244
- https://doi.org/10.1016/s0031-3955(16)33255-2
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- RETURN OF SPERMATOGENESIS AFTER STOPPING CYCLOPHOSPHAMIDE THERAPYThe Lancet, 1975
- Constrictive Pericarditis in Childhood Due to Mediastinal IrradiationCirculation, 1974
- Evidence for a Specific Seminiferous Tubular Factor Affecting Follicle-Stimulating Hormone Secretion in ManJournal of Clinical Investigation, 1972
- Methotrexate Hepatotoxicity in Psoriasis--Comparison of Different Dose RegimensBMJ, 1972
- Abnormal Zygote Development in Mice after Paternal Exposure to a Chemical MutagenNature, 1970
- CARDIAC TOXICITY OF DAUNORUBICINThe Lancet, 1969
- CYTOTOXIC DRUGS IN PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1968
- The teratogenic effect of vincaleukoblastine in the pregnant ratThe Journal of Pediatrics, 1965
- Hepatic fibrosis in children with acute leukemia.A complication of therapyCancer, 1960
- BUSULFAN (1,4‐DIMETHANESULFONYLOXYBUTANE, MYLERAN): SUMMARY OF CLINICAL, RESULTSAnnals of the New York Academy of Sciences, 1958